Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

22 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle lab results Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle lab results Haematology 2009-011417-24

- 01/12/2016 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Chemotherapy Regimen, Laboratory Tests
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Additional week laboratory results Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Additional week laboratory results Blood/ Urinanalysis 2009-011417-24

- 01/12/2016 - 1 Formulário, 3 Grupos de itens, 32 Elementos de dados, 1 Idioma
Grupos de itens: Chemotherapy Regimen, Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24

- 01/12/2016 - 1 Formulário, 2 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23/11/2016 - 1 Formulário, 2 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24

- 23/11/2016 - 1 Formulário, 2 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Haematology 2009-011417-24

- 23/11/2016 - 1 Formulário, 1 Grupo de itens, 20 Elementos de dados, 1 Idioma
Grupo de itens: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Haematology 2009-011417-24

- 23/11/2016 - 1 Formulário, 1 Grupo de itens, 20 Elementos de dados, 1 Idioma
Grupo de itens: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Haematology 2009-011417-24

- 23/11/2016 - 1 Formulário, 1 Grupo de itens, 20 Elementos de dados, 1 Idioma
Grupo de itens: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23/11/2016 - 1 Formulário, 2 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Haematology 2009-011417-24

- 23/11/2016 - 1 Formulário, 1 Grupo de itens, 23 Elementos de dados, 1 Idioma
Grupo de itens: Laboratory results hematology
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Blood/ Urinanalysis 2009-011417-24

- 23/11/2016 - 1 Formulário, 2 Grupos de itens, 31 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Haematology 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Haematology 2009-011417-24

- 23/11/2016 - 1 Formulário, 2 Grupos de itens, 25 Elementos de dados, 1 Idioma
Grupos de itens: Laboratory results hematology, Pharmacokinetics (PK)
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial